A5019991786- Colorectal Cancer Treatments and Studies
- Lung Cancer Treatments and Mutations
- Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Gastric Cancer Management and Outcomes
- Inflammatory Biomarkers in Disease Prognosis
- Cancer, Lipids, and Metabolism
- Colorectal and Anal Carcinomas
- Salivary Gland Tumors Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- HER2/EGFR in Cancer Research
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
- Colorectal Cancer Surgical Treatments
- Gastrointestinal Tumor Research and Treatment
- Sarcoma Diagnosis and Treatment
- Head and Neck Cancer Studies
- Cardiac tumors and thrombi
- Ovarian cancer diagnosis and treatment
- Renal cell carcinoma treatment
Erciyes Üniversitesi Tıp Fakültesi Hastaneleri
2025
Necmettin Erbakan University
2015-2024
Erciyes University
2024
Pfizer (United States)
2024
Pfizer (United Kingdom)
2024
Roche (Switzerland)
2024
AstraZeneca (Brazil)
2024
Novartis (Switzerland)
2024
Weatherford College
2024
Ankara University
2020-2023
The clinical feature of breast cancer is very heterogeneous because the variable prognostic factors impact its behaviour. aim study to find importance Ki-67 and analyse correlation between index other conventional in patients.Between 2010 2017, patients with invasive ductal carcinoma who received radiotherapy after surgery were included study. A single pathologist re-defined all cases retrospectively. established three categories based on levels: low (<10%), intermediate (10-25%) high...
Abstract: Background Male breast cancer is a sporadic disease and only one in every 100 new patients male. There are few satisfactory clinical studies on male cancers the literature. We aim to share clinicopathologic demographic characteristics of admitted our clinic last 12 years experience treatment these patients. Methods The data who were referred with diagnosis cancer, suspicion or presented outpatient symptoms discharge, palpable mass diagnosed malignancy between 2010 2022...
The aim of this study was to determine whether surgical resection the primary tumor contributes survival in patients with metastatic gastric cancer.A total 288 cancer from Akdeniz University, Antalya Training and Research Hospital, Meram University Konya database were retrospectively analyzed. effect on investigated using log-rank test. Kaplan-Meier estimates calculated. Multivariate analysis performed Cox proportional hazards regression modeling.The median overall 12.0 months (95%...
A high-risk group of patients with stage II colon cancer has been identified by the results studies in Western populations. The aim this study was to investigate prognostic factors adjuvant chemotherapy Turkish cancer.A total 554 were retrospectively enrolled study. Three hundred fifty-three had received (5-FU-LV, FOLFOX or FLOX) and 201 no chemotherapy. T4 tumor stage, lymphovascular invasion, perineural bowel obstruction and/or perforation, <12 harvested lymph nodes, poor differentiation...
It is red cell distribution width (RDW) that has been reported to show an inflammatory response which studied recently. The aim of this study investigate whether the pre-treatment RDW in patients using first-line vascular endothelial growth factor tyrosine kinase inhibitor (VEGFR TKI) with diagnosis metastatic renal carcinoma (mRCC) predicts treatment and a prognostic or not.About 92 diagnosed mRCC who were being treated sunitinib pazopanib first line between January 2015 June 2021 included...
A high-risk group of patients with stage II colon cancer has been identified by the results studies in Western populations. The aim this study was to investigate prognostic factors adjuvant chemotherapy Turkish cancer.A total 554 were retrospectively enrolled study. Three hundred fifty-three had received (5-FU-LV, FOLFOX or FLOX) and 201 no chemotherapy. T4 tumor stage, lymphovascular invasion, perineural bowel obstruction and/or perforation, <12 harvested lymph nodes, poor differentiation...
Cisplatin-paclitaxel and bevacizumab is a frequently used treatment regimen for metastatic or recurrent cervical cancer, carboplatin-paclitaxel are also among the recommended regimens. In this study we aimed to evaluate efficacy of these two regimens cancer.Patients with cancer treated cisplatin-paclitaxel were retrospectively evaluated in study. The clinical demographic characteristics patients each group evaluated. Median overall survival, progression-free response rates between groups...
<b><i>Background:</i></b> Colorectal cancer (CRC) is a rare disease amongst children and adolescents. Previous studies have reported number of differences between children/adolescents, young adults, adult patients with CRC. However, none these compared age groups according to their clinicopathologic prognostic characteristics. In the current study, we compare three groups. <b><i>Methods:</i></b>A total 173 (1.1% 15,654 patients) CRC (≤25 years)...
The prognosis of patients with advanced HCC can vary widely depending on factors such as the stage cancer, patient's overall health, and treatment regimens. This study aimed to investigate survival outcomes associated in hepatocellular carcinoma (HCC). In this retrospective study, data from 23 medical oncology clinics were analyzed. Progression-free (PFS) (OS) values estimated using Kaplan–Meier method. Prognostic which identified univariate analysis subsequently evaluated a multivariate...
Identification of biomarkers used for the prognostic evaluation non-small cell lung cancer (NSCLC) patients is important. The aim this study was to evaluate potential value XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms (SNPs) in completely resected NSCLC patients. In total, 130 patients, surgically treated between 2000 2012, were included. An analysis SNPs from peripheral blood cells performed by polymerase chain reaction. XRCC1 Arg399Gln, ERCC1 Asn118Asn, ERCC2 Lys751Gln,...
Introduction Soft tissue sarcomas are a heterogeneous and rare group of cancers with short median overall survival despite the chemotherapy. Pazopanib has approval for treatment advanced soft sarcoma. We aimed to investigate clinical outcomes Turkish patients sarcoma who received pazopanib. Patients methods This was retrospective study. The inclusion criteria were: ≥18 years age, having histologically proven receiving pazopanib at least one day. Results A total 79 were assessed in this age...
Trastuzumab emtansine (TDM-1) is an antibody-drug conjugate effective in human epidermal growth factor receptor-2 - expressing advanced breast cancer. Pulmonary complications of TDM-1 are rarely reported. TDM-1-associated interstitial lung disease referred to as pneumonitis.A 47-year-old female patient who underwent modified radical mastectomy and axillary lymph node dissection operations due a palpable mass the right region. The had received multiple chemotherapy was last receiving...
Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number patients, including only major or minor SGCs, epidemiological data.A total 37 medical oncology clinics from different regions Turkey participated in this retrospective-multicenter study. The analyzed data included clinical and demographical features, primary treatment, metastasis localizations, treatments includes certain pathologic features.The study a 443 SGCs. 56.7% was...